A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
March 2-3 | Virtual & Orlando, FL
The University of Florida College of Pharmacy has partnered with GenomeWeb’s Precision Medicine Leaders’ Summit to produce this event, which will be in-person and live streamed.
Updates in Precision Medicine and Pharmacogenomics will highlight the evolving role of molecular profiling in guiding pharmacotherapy decision-making – from new developments in pharmacogenomics to the use of companion diagnostics, polygenic risk scores, and other biomarker strategies.
Visit the Updates in Precision Medicine conference website for more information and to register.
GMKB